List of Tables
Table 1. Global RNA Modifying Agents Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global RNA Modifying Agents Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global RNA Modifying Agents Market Competitive Situation by Manufacturers in 2025
Table 4. Global RNA Modifying Agents Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global RNA Modifying Agents Sales Market Share by Manufacturers (2021–2026)
Table 6. Global RNA Modifying Agents Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global RNA Modifying Agents Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market RNA Modifying Agents Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of RNA Modifying Agents, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of RNA Modifying Agents, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of RNA Modifying Agents, Product Types and Applications
Table 12. Global Key Manufacturers of RNA Modifying Agents, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global RNA Modifying Agents Companies by Tier (Tier 1, Tier 2, Tier 3), based on RNA Modifying Agents Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global RNA Modifying Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global RNA Modifying Agents Sales by Region (K Units), 2021–2026
Table 18. Global RNA Modifying Agents Sales Market Share by Region (2021–2026)
Table 19. Global RNA Modifying Agents Sales by Region (K Units), 2027–2032
Table 20. Global RNA Modifying Agents Sales Market Share by Region (2027–2032)
Table 21. Global RNA Modifying Agents Revenue by Region (US$ Million), 2021–2026
Table 22. Global RNA Modifying Agents Revenue Market Share by Region (2021–2026)
Table 23. Global RNA Modifying Agents Revenue by Region (US$ Million), 2027–2032
Table 24. Global RNA Modifying Agents Revenue Market Share by Region (2027–2032)
Table 25. North America RNA Modifying Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America RNA Modifying Agents Sales by Country (K Units), 2021–2026
Table 27. North America RNA Modifying Agents Sales by Country (K Units), 2027–2032
Table 28. North America RNA Modifying Agents Revenue by Country (US$ Million), 2021–2026
Table 29. North America RNA Modifying Agents Revenue by Country (US$ Million), 2027–2032
Table 30. Europe RNA Modifying Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe RNA Modifying Agents Sales by Country (K Units), 2021–2026
Table 32. Europe RNA Modifying Agents Sales by Country (K Units), 2027–2032
Table 33. Europe RNA Modifying Agents Revenue by Country (US$ Million), 2021–2026
Table 34. Europe RNA Modifying Agents Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific RNA Modifying Agents Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific RNA Modifying Agents Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific RNA Modifying Agents Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific RNA Modifying Agents Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific RNA Modifying Agents Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America RNA Modifying Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America RNA Modifying Agents Sales by Country (K Units), 2021–2026
Table 42. Latin America RNA Modifying Agents Sales by Country (K Units), 2027–2032
Table 43. Latin America RNA Modifying Agents Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America RNA Modifying Agents Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa RNA Modifying Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa RNA Modifying Agents Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa RNA Modifying Agents Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa RNA Modifying Agents Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa RNA Modifying Agents Revenue by Country (US$ Million), 2027–2032
Table 50. Global RNA Modifying Agents Sales (K Units) by Type (2021–2026)
Table 51. Global RNA Modifying Agents Sales (K Units) by Type (2027–2032)
Table 52. Global RNA Modifying Agents Sales Market Share by Type (2021–2026)
Table 53. Global RNA Modifying Agents Sales Market Share by Type (2027–2032)
Table 54. Global RNA Modifying Agents Revenue (US$ Million) by Type (2021–2026)
Table 55. Global RNA Modifying Agents Revenue (US$ Million) by Type (2027–2032)
Table 56. Global RNA Modifying Agents Revenue Market Share by Type (2021–2026)
Table 57. Global RNA Modifying Agents Revenue Market Share by Type (2027–2032)
Table 58. Global RNA Modifying Agents Price (US$/Unit) by Type (2021–2026)
Table 59. Global RNA Modifying Agents Price (US$/Unit) by Type (2027–2032)
Table 60. Global RNA Modifying Agents Sales (K Units) by Application (2021–2026)
Table 61. Global RNA Modifying Agents Sales (K Units) by Application (2027–2032)
Table 62. Global RNA Modifying Agents Sales Market Share by Application (2021–2026)
Table 63. Global RNA Modifying Agents Sales Market Share by Application (2027–2032)
Table 64. Global RNA Modifying Agents Revenue (US$ Million) by Application (2021–2026)
Table 65. Global RNA Modifying Agents Revenue (US$ Million) by Application (2027–2032)
Table 66. Global RNA Modifying Agents Revenue Market Share by Application (2021–2026)
Table 67. Global RNA Modifying Agents Revenue Market Share by Application (2027–2032)
Table 68. Global RNA Modifying Agents Price (US$/Unit) by Application (2021–2026)
Table 69. Global RNA Modifying Agents Price (US$/Unit) by Application (2027–2032)
Table 70. Active Motif Company Information
Table 71. Active Motif Description and Business Overview
Table 72. Active Motif RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Active Motif RNA Modifying Agents Product
Table 74. Active Motif Recent Developments/Updates
Table 75. Epigentek Company Information
Table 76. Epigentek Description and Business Overview
Table 77. Epigentek RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Epigentek RNA Modifying Agents Product
Table 79. Epigentek Recent Developments/Updates
Table 80. Thermo Fisher Scientific Company Information
Table 81. Thermo Fisher Scientific Description and Business Overview
Table 82. Thermo Fisher Scientific RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Thermo Fisher Scientific RNA Modifying Agents Product
Table 84. Thermo Fisher Scientific Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck RNA Modifying Agents Product
Table 89. Merck Recent Developments/Updates
Table 90. Gene Link Company Information
Table 91. Gene Link Description and Business Overview
Table 92. Gene Link RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Gene Link RNA Modifying Agents Product
Table 94. Gene Link Recent Developments/Updates
Table 95. abcam Company Information
Table 96. abcam Description and Business Overview
Table 97. abcam RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. abcam RNA Modifying Agents Product
Table 99. abcam Recent Developments/Updates
Table 100. ABclonal Company Information
Table 101. ABclonal Description and Business Overview
Table 102. ABclonal RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. ABclonal RNA Modifying Agents Product
Table 104. ABclonal Recent Developments/Updates
Table 105. MyBioSource Company Information
Table 106. MyBioSource Description and Business Overview
Table 107. MyBioSource RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. MyBioSource RNA Modifying Agents Product
Table 109. MyBioSource Recent Developments/Updates
Table 110. Beyotime Company Information
Table 111. Beyotime Description and Business Overview
Table 112. Beyotime RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Beyotime RNA Modifying Agents Product
Table 114. Beyotime Recent Developments/Updates
Table 115. Hologic Company Information
Table 116. Hologic Description and Business Overview
Table 117. Hologic RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Hologic RNA Modifying Agents Product
Table 119. Hologic Recent Developments/Updates
Table 120. Synaptic Systems Company Information
Table 121. Synaptic Systems Description and Business Overview
Table 122. Synaptic Systems RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Synaptic Systems RNA Modifying Agents Product
Table 124. Synaptic Systems Recent Developments/Updates
Table 125. Novus Biologicals Company Information
Table 126. Novus Biologicals Description and Business Overview
Table 127. Novus Biologicals RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Novus Biologicals RNA Modifying Agents Product
Table 129. Novus Biologicals Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. RNA Modifying Agents Distributors List
Table 133. RNA Modifying Agents Customers List
Table 134. RNA Modifying Agents Market Trends
Table 135. RNA Modifying Agents Market Drivers
Table 136. RNA Modifying Agents Market Challenges
Table 137. RNA Modifying Agents Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of RNA Modifying Agents
Figure 2. Global RNA Modifying Agents Market Value by Type (US$ Million), 2021–2032
Figure 3. Global RNA Modifying Agents Market Share by Type: 2025 & 2032
Figure 4. N6-Methyladenosine (m6A) Antibody Product Picture
Figure 5. 5-Methylcytosine (5-mC) Antibody Product Picture
Figure 6. Others Product Picture
Figure 7. Global RNA Modifying Agents Market Value by Application (US$ Million), 2021–2032
Figure 8. Global RNA Modifying Agents Market Share by Application: 2025 & 2032
Figure 9. Gene Therapy
Figure 10. Cancer Research
Figure 11. Drug Development
Figure 12. Other
Figure 13. Global RNA Modifying Agents Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global RNA Modifying Agents Market Size (US$ Million), 2021–2032
Figure 15. Global RNA Modifying Agents Sales (K Units), 2021–2032
Figure 16. Global RNA Modifying Agents Average Price (US$/Unit), 2021–2032
Figure 17. RNA Modifying Agents Report Years Considered
Figure 18. RNA Modifying Agents Sales Share by Manufacturers in 2025
Figure 19. Global RNA Modifying Agents Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global RNA Modifying Agents Players: Market Share by Revenue in RNA Modifying Agents in 2025
Figure 21. RNA Modifying Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global RNA Modifying Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America RNA Modifying Agents Sales Market Share by Country (2021–2032)
Figure 24. North America RNA Modifying Agents Revenue Market Share by Country (2021–2032)
Figure 25. United States RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe RNA Modifying Agents Sales Market Share by Country (2021–2032)
Figure 28. Europe RNA Modifying Agents Revenue Market Share by Country (2021–2032)
Figure 29. Germany RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific RNA Modifying Agents Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific RNA Modifying Agents Revenue Market Share by Region (2021–2032)
Figure 36. China RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America RNA Modifying Agents Sales Market Share by Country (2021–2032)
Figure 44. Latin America RNA Modifying Agents Revenue Market Share by Country (2021–2032)
Figure 45. Mexico RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa RNA Modifying Agents Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa RNA Modifying Agents Revenue Market Share by Country (2021–2032)
Figure 51. Turkey RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE RNA Modifying Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of RNA Modifying Agents by Type (2021–2032)
Figure 55. Global Revenue Market Share of RNA Modifying Agents by Type (2021–2032)
Figure 56. Global RNA Modifying Agents Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of RNA Modifying Agents by Application (2021–2032)
Figure 58. Global Revenue Market Share of RNA Modifying Agents by Application (2021–2032)
Figure 59. Global RNA Modifying Agents Price (US$/Unit) by Application (2021–2032)
Figure 60. RNA Modifying Agents Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
